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Figure 1. Nuclear and Centrosome Positioning in Rescue Experiments. NIH3T3 fibroblasts were 
treated with siRNA against LAP1. Cells at the wound edge were starved, injected with the indicated 
GFP LAP1 construct, stimulated with LPA, and the nuclear and centrosome positions were measured 
and compared to cells treated with non-coding siRNA. The cell center corresponds to 0 on the y-axis. 
Numbers in parentheses represent number of measured cells for each treatment. Asterisks below bars 
show significance between treatment and LAP1 knockdown nuclear positioning. 
* = p< 0.05, ** = p < 0.01, *** = p <0.001, **** = p < 0.0001 
Figure 2. Nuclear-Centrosomal Axis Orientation in Rescue Experiments. Orientation of 
the nuclear-centrosomal axis was scored in uninjected and injected LAP1 knockdown 
fibroblasts at the wound edge. Numbers in parentheses represent number of replicates. 
Asterisks above bars show significance between treatment and LAP1 knockdown 
centrosome orientation. * = p< 0.05, ** = p < 0.01, *** = p <0.001, **** = p < 0.0001 
 
• Treatment of fibroblasts with LAP1 siRNA inhibited nuclear positioning and decreased orientation of wound edge cells 
compared to cells treated with non-coding control siRNA. 
• GFP-LAP1WT rescued nuclear positioning and nuclear-centrosomal axis orientation in cells treated with LAP1 siRNA. 
• The GFP-LAP1R563E mutant rescued nuclear positioning and orientation more strongly than GFP-LAP1WT, suggesting 
R563E may be a gain of function mutation. 
• The GFP LAP1R563A and GFP LAP1C496S mutants rescued nuclear positioning and orientation to WT levels, suggesting 
that both amino acids are dispensable for LAP1 function. 
• The GFP LAP1C424S and GFP LAP1C582S mutants did not rescue nuclear positioning or orientation, suggesting that this 
intramolecular disulfide bond in the LAP1 luminal domain is important for nuclear positioning. 
• GFP tagged LAP1 constructs were created: wild type (WT), R563E, R563A, C496S, C424S, and C582S 
• NIH3T3 fibroblasts were treated with LAP1 siRNA and allowed to grow on glass coverslips for 48 hours. 
• Fibroblasts were serum-starved for 24 hours to induce quiescence. 
• Artificial wounds were created and wound edge cells microinjected with LAP1 constructs. 
• Fibroblasts were stimulated with the serum component, lysophosphatidic acid (LPA), which induces 
polarization toward the wound edge. 
• Cells were fixed after two hours of stimulation and visualized using immunofluorescence. 
• Using custom MATLab code, nuclear and centrosome positioning and orientation of the nuclear-centrosomal 
axis toward the wound edge were measured as follows. 
• Early-onset torsion dystonia is a neurological disorder caused by a 
mutation deleting a single glutamate residue in the AAA+ ATPase, 
TorsinA (1), however the disease etiology is poorly understood.  
• TorA regulates nuclear movement and positioning through interaction 
with the LINC complex, a nuclear envelope complex required for 
nuclear movement in polarizing fibroblasts (2). 
• TorA is activated by Lamina-Associated Polypeptide 1 (LAP1), an 
inner nuclear membrane protein (3). 
• Crystal structure of the LAP1 luminal domain suggests R563 
required for TorA stimulation (4). 
• Structural data also suggests C424 and C582 form an intramolecular 
disulfide bond that may be important for LAP1 function (4).  
• C496 is highly conserved and may be important in TorA stimulation 
(4) 
• To test these predictions, we created GFP-tagged LAP1 constructs 
with mutations in these residues. 
• Tested ability of constructs to rescue nuclear positioning in cells 
treated with LAP1 siRNA using the wounded fibroblast monolayer 
system (5). 
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Torsion dystonia is a neurological disease caused by a mutation in 
DYT1. This gene encodes the AAA+ ATPase, TorsinA (TorA), 
which is involved in regulating nuclear movement in polarizing 
fibroblasts. The mechanism by which this mutation causes torsion 
dystonia is not understood. The inner nuclear envelope protein 
Lamina-Associated Polypeptide 1 (LAP1) is required to activate 
TorA ATPase activity. The crystal structure of the LAP1 luminal 
domain suggests that arginine 563 is necessary to activate TorA. 
It also suggests that cysteine 424 and 582 form an intramolecular 
disulfide bond that may be important for the LAP1 luminal 
domain to adapt the correct structure. In addition, cysteine 496 is 
highly conserved and may play a role in TorA activation. TorA 
knockout fibroblasts exhibit defects in nuclear positioning. Using 
the wounded fibroblast monolayer system we found that siRNA 
knockdown of LAP1 inhibited nuclear positioning in polarizing 
fibroblasts. This nuclear positioning defect was rescued by 
microinjection of cDNA constructs encoding GFP-LAP1WT and 
GFP-LAP1 with either R563E, R563A, or C496S mutations. The 
nuclear positioning defect was not rescued by microinjection of 
cDNA construct encoding GFP-LAP1 with either C424S or C582 
mutations.  
1. Wound edge is defined by drawing 
line between contact points with two 
adjacent cells . 
2. Cell border is traced and 
centrosomes are defined. 
3. Distance of nucleus and 
centrosome from cell centroid along 
axis perpendicular to the wound edge 
is measured. 
4. Cell is scored as oriented if the 
nuclear-centrosomal axis passes 
through the wound edge. 
• Since GFP-LAP1R563E showed greater rearward 
nuclear positioning than GFP-LAP1WT incells 
treated with LAP1 siRNA, we may want to test the 
hypothesis that this is a gain of function mutation 
by overexpressing this construct in both 
unstimulated and stimulated 3T3s to test whether 
nuclear positioning and orientation are enhanced. 
• Since the both C424 and C582 were important for 
LAP1 function, we want to make the double mutant 
construct (GFP-LAP1C424S/C582S) to test whether 
inhibition of nuclear positioning and orientation is 
worsened. 
• Generate GFP-LAP1 luminal domain and 
nucleoplasmic domain cDNA constructs to test 
whether either domain alone is sufficient to rescue 
nuclear positioning and orientation. 
• Generate GFP-LAP1 constructs with point mutants 
at other conserved arginine residues and perform 
rescue experiments to study whether other arginine 













Zoomed in view of the crystal structure of LAP1 
TorA interface, showing LAP1 R563 in close 
proximity to the TorA ATP binding site. (6) 
